38.78 USD
-1.44 (-3.57%)
38.78 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to IMCR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 69.09. This target is 78.15% above the current price.
IMCR was analyzed by 23 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about IMCR.
In the previous month the buy percentage consensus was at a similar level.
IMCR was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-31 | Wells Fargo | Initiate | Overweight |
| 2025-10-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-10 | Needham | Reiterate | Buy -> Buy |
| 2025-04-07 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-03-12 | Needham | Reiterate | Buy -> Buy |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-27 | Needham | Reiterate | Buy -> Buy |
| 2025-01-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | Needham | Reiterate | Buy -> Buy |
| 2024-12-13 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-11-11 | Mizuho | Downgrade | Outperform -> Neutral |
| 2024-11-07 | Needham | Maintains | Buy -> Buy |
| 2024-10-24 | UBS | Initiate | Sell |
| 2024-10-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-10-07 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-09-17 | Needham | Maintains | Buy -> Buy |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | Needham | Reiterate | Buy -> Buy |
| 2024-08-09 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-08-09 | Barclays | Maintains | Overweight -> Overweight |
| 2024-07-10 | JP Morgan | Maintains | Overweight -> Overweight |
IMMUNOCORE HOLDINGS PLC-ADR / IMCR FAQ
What is the price target for IMCR stock?
23 analysts have analysed IMCR and the average price target is 69.09 USD. This implies a price increase of 78.15% is expected in the next year compared to the current price of 38.78.
How do analysts rate IMMUNOCORE HOLDINGS PLC-ADR (IMCR)?
The consensus rating for IMMUNOCORE HOLDINGS PLC-ADR (IMCR) is 81.7391 / 100 . This indicates that analysts generally have a positive outlook on the stock.